Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN)

NCT01788332 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Olaparib
OTHER: Placebo

Sponsor

Lisette Nixon

Collaborators

[object Object]